“Blockbuster ingredient”: ChromaDex receives EFSA approval for nicotinamide riboside chloride

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

17 Jan 2020 --- This week in nutrition news, the US Chair of the House Agriculture Committee introduced legislation that could provide the Food and Drug Administration (FDA) with... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

15 Jan 2020 --- Enovate Biolife’s botanical ingredient Lanconone can provide joint pain relief within three hours of the first dose. Available in North American and Asian... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Jan 2020 --- Glucomannan, which is found in the root of the konjac plant (also known as the elephant yam), is set to be added to the US definition of dietary fiber. The Food and... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

09 Jan 2020 --- In response to increasing numbers of consumers living under oxidative stress from urban and industrialized areas, French nutricosmetics manufacturer Laboratoire PYC... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

08 Jan 2020 --- Nutraceutical company ChromaDex has initiated a Phase 1 clinical study to assess the potential of its branded nicotinamide riboside (NR), Niagen. Sponsored by the... Read More

trans